CDH11 and adenocarcinoma: Data obtained from TIMER and GEPIA showed similar results, with high levels of CDH11 expression shown to be more common in adenocarcinoma like breast, gastric, pancreatic, and colorectal cancers, while lower expression mainly existed in tumors of the urinary and respiratory systems (Figure 1(b) and Figure S1).